Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan

Published:2016-10-19 Issue:1 Volume:105 Page:59-69
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Takenaka Katsuto,Shimoda Kazuya,Uchida Naoyuki,Shimomura Taizo,Nagafuji Koji,Kondo Tadakazu,Shibayama Hirohiko,Mori Takehiko,Usuki Kensuke,Azuma Taichi,Tsutsumi Yutaka,Tanaka Junji,Dairaku Hitomi,Matsuo Keitaro,Ozawa Keiya,Kurokawa Mineo,Arai Shunya,Akashi Koichi

Funder

Grant-in-Aid for Scientific Research (C)

Grant-in-Aid for Scientific Research (S)

Health Labour Sciences Research Grant

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-016-2102-3.pdf

Reference34 articles.

1. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937–51 Epub 2009/04/10.

2. Cervantes F, Dupriez B, Pereira A, Passamonti F, Reilly JT, Morra E, et al. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for myelofibrosis research and treatment. Blood. 2009;113(13):2895–901 Epub 2008/11/08.

3. Cervantes F, Passamonti F, Barosi G. Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders. Leukemia. 2008;22(5):905–14 Epub 2008/04/04.

4. Tefferi A, Guglielmelli P, Larson DR, Finke C, Wassie EA, Pieri L, et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood. 2014;124(16):2507–13 (quiz 615. Epub 2014/07/20).

5. Dupriez B, Morel P, Demory JL, Lai JL, Simon M, Plantier I, et al. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood. 1996;88(3):1013–8.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives;Frontiers in Oncology;2024-07-24

2. Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis;Annals of Hematology;2023-11-10

3. Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis;British Journal of Haematology;2022-09-12

4. IV．骨髄増殖性腫瘍の初期診断と外来治療;Nihon Naika Gakkai Zasshi;2022-07-10

5. Philadelphia chromosome-negative myeloproliferative neoplasms: clinical aspects and treatment options;International Journal of Hematology;2022-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3